RESUMO
The modification of CeO2 with rare-earth elements opens up a wide range of applications as biomedical devices using infrared emission as well as magnetic and gas-sensing devices, once the structural, morphological, photoluminescent, magnetic, electric, and gas-sensing properties of these systems are strongly correlated to quantum electronic transitions between rare-earth f-states among defective species. Quantitative phase analysis revealed that the nanopowders are free from secondary phases and crystallize in the fluorite-type cubic structure. Magnetic coercive field measurements on the powders indicate that the substitution of cerium with lanthanum (8 wt %), in a fluorite-type cubic structure, created oxygen vacancies and led to a decrease in the fraction of Ce species in the 3+ state, resulting in a stronger room-temperature ferromagnetic response along with high coercivity (160 Oe). In addition to the magnetic and photoluminescent behavior, a fast response time (5.5 s) was observed after CO exposure, indicating that the defective structure of ceria-based materials corresponds to the key of success in terms of applications using photoluminescent, magnetic, or electrical behaviors.
RESUMO
Ischemia-reperfusion injury (IRI) is a common complication after lung transplantation. There is evidence that reactive oxygen species are involved in its pathogenesis. We designed an experimental study to evaluate whether the administration of antioxidants to lung transplantation recipients protects against IRI and early acute rejection (AR). Twenty-five rats received left lung transplants after 6 h of ischemia. Fifty minutes before the reperfusion, groups of five rats received a single dose of desferrioxamine (20 mg/kg), estradiol (25 mg/kg), or melatonin (10 mg/kg). The animals were killed 48 h after surgery and the postoperative outcome, IRI, and AR were evaluated. The frequency of severe injury and of moderate-to-severe edema was higher in animals treated with estradiol than in the control group (P = 0.022 and P = 0.026, respectively). No significant changes in the degree of IRI or AR were observed in the groups treated with desferrioxamine or melatonin. In our study, treatment with the antioxidants melatonin or desferrioxamine before reperfusion had no effects on IRI damage or on AR frequency or severity. However, treatment with estradiol resulted in a worse postoperative outcome and in severe edema. Therefore, despite the antioxidant capacity of estradiol, it is recommended that an evaluation of these adverse effects of estradiol in human lung transplant recipients be performed.
